NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.
Don't have an account? Register
ADVERTISEMENT
ADVERTISEMENT
The inaugural Joint Irish-UK Endocrine Meeting, which took place in the International Cultural Centre, Belfast, from...
GLPG5101. Dr Marie José Kersten, Professor of Haematology at Amsterdam University Medical Centres, Netherlands, presented promising...
Women who experience premature ovarian insufficiency (POI) before the age of 40 are more likely to...
In November 2025, the US Food and Drug Administration (FDA) approved epcoritamab with rituximab and lenalidomide...
New research presented at the 67th American Society of Hematology (ASH) Annual Meeting in December 2025...
First results from the phase 3 GIMEMA ALL2820 trial suggest chemotherapy-free combination treatment outperforms a combination...
Patients newly diagnosed with acute myeloid leukaemia (AML) who are eligible for intensive chemotherapy fare significantly...
BTK. Also presented at the ASH Annual Meeting were the results from the first randomised phase...
Video-observed therapy (VOT) is among the measures needed to enhance tuberculosis (TB) care in Ireland, heard...
Hidradenitis suppurativa (HS), also known as Verneuil disease, acne inversa, or terminal hair dissecting folliculitis, is...
Heart failure with preserved ejection fraction (HFpEF) has emerged as one of the most significant clinical...
Despite significant progress in recent years, tobacco use remains a major public health challenge in Ireland....
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT